8-K: Surrozen Director Shao-Lee Lin Resigns
Director Resignation
Dr. Shao-Lee Lin has resigned from Surrozen, Inc.'s Board of Directors, effective January 26, 2026, with no reported disagreements.
Summary
- Shao-Lee Lin, M.D., Ph.D. resigned from the Board of Directors of Surrozen, Inc. on January 26, 2026.
- The resignation was effective immediately.
- The Company stated that Dr. Lin's resignation was not due to any disagreement with Surrozen, Inc. regarding its operations, policies, or practices.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While any director departure warrants attention, the explicit statement that it was not due to disagreement prevents it from being a negative signal, positioning it as a routine corporate governance update.
Positives
- The company explicitly stated that Dr. Lin's resignation was not due to any disagreement, mitigating concerns about internal conflict or strategic divergence.
Negatives
- The departure of a director, even if amicable, can represent a loss of expertise, experience, and continuity on the Board.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- "The Company thanks Dr. Lin for her service and dedication to the Company's mission."
Industry Context
StockSavvy.ai notes that director resignations are a common occurrence in the biotech and pharmaceutical sectors, often due to evolving personal commitments, new opportunities, or strategic shifts within the company or the director's own career. The explicit statement of 'no disagreement' is crucial in this industry, as it helps to allay investor fears of internal strife or fundamental strategic issues, which can be particularly damaging for development-stage companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Shao-Lee Lin, M.D., Ph.D. | January 26, 2026 | Resignation, not due to disagreement with company operations, policies, or practices. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition Change | Shao-Lee Lin, M.D., Ph.D. resigned from the Board of Directors. | January 26, 2026 | The Board will now operate with one less director, potentially requiring a search for a replacement to maintain optimal board size and expertise, though the immediate impact is minimal given the stated amicable nature of the departure. |
Stakeholder Impact
- Shareholders: Minor impact, as the resignation was not due to disagreement, reducing concerns about internal instability. However, it represents a loss of a board member's oversight and expertise.
- Employees: No direct impact mentioned or implied by this filing.
Key Dates
| Date | Description |
|---|---|
| January 26, 2026 | Effective date of Shao-Lee Lin's resignation from the Board of Directors. |
| January 30, 2026 | Date the 8-K report was signed by Charles Williams, Chief Operating Officer. |
Keywords
Surrozen, SRZN, Board of Directors, Director Resignation, Corporate Governance, Shao-Lee Lin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.